|Bid Price||-||Offer Price||-|
|Mid Price||GBX 119.88||Day Change||GBX -0.21 (-0.17%)|
|Price Date||20 Oct 2017||Crown Rating|
|Shares Class||Inc.||Yield||0.00 %|
|Total Expense Ratio||0.00||Fund Size||152,100,000.00|
|Launch Date||10/11/2008||Standard Initial Charge (%)||0.00|
|Annual Management Charge (%)||0.75||Sector||IMA UK Equity Income|
|Min Investment (£)||1,000.00||Total Expense Ratio (%)||0.00|
|ISIN||GB00B7VHZX64||Min TopUp (£)||10,000.00|
The Fund seeks to achieve long-term capital growth primarily through investment in US equities with growth characteristics.
Peter Bye is a Portfolio Manager on the US Large Cap Growth Equity team. In addition to his portfolio management responsibilities, he is responsible for analysis and issue selection in the health care sector. Peter joined UBS Global Asset Management in 2010 after twelve years in equity research on the sell side covering health care sectors at Cowen & Co., Citigroup, Wachovia and most recently at Jefferies and Co. where he was mentioned as one of the Best on the Street in the 2010 Wall Street Journal survey.Prior to his equity research career, Peter worked in the quantitative research department at Putnam Investments in Boston, analyzing portfolio strategies, risk, security modeling, and performance attribution among the companies taxable fixed income groups.